Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28834174 | 0.97 | THRB (0.38) | THRBDNM1LMNAOPRM1SMPD1 | |
| SCHEMBL3380382 | 0.92 | OPRM1 (0.48) | THRBDNM1LMNAOPRM1SMPD1 | |
| SCHEMBL872866 | 0.89 | SMPD1 (0.48) | THRBDNM1LMNAOPRM1SMPD1 | |
| SCHEMBL113618 | 0.89 | SMPD1 (0.48) | THRBDNM1LMNAOPRM1SMPD1 | |
| SCHEMBL3506094 | 0.89 | SMPD1 (0.48) | THRBDNM1LMNAOPRM1SMPD1 | |
| SCHEMBL7549190 | 0.89 | SMPD1 (0.48) | THRBDNM1LMNAOPRM1SMPD1 | |
| SCHEMBL8930848 | 0.89 | SMPD1 (0.48) | THRBDNM1LMNAOPRM1SMPD1 | |
| SCHEMBL6666312 | 0.89 | SMPD1 (0.48) | THRBDNM1LMNAOPRM1SMPD1 | |
| SCHEMBL21484061 | 0.89 | SMPD1 (0.48) | THRBDNM1LMNAOPRM1SMPD1 | |
| SCHEMBL3506724 | 0.89 | SMPD1 (0.48) | THRBDNM1LMNAOPRM1SMPD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114573437-A | Production method of trans-2, 4-nonadienal | 滕州市天水生物科技有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-110305487-A | Visible-light curing organosilicon composite material and preparation method | 点铂医疗科技（常州）有限公司 | 2019-10-08 | — | — | CN | claimed |
| CN-103044586-B | A kind of catalyst component for vinyl polymerization, preparation method and application | SINOPEC CORP. (CN) | 2015-09-16 | — | — | CN | claimed |
| CN-104788492-A | Oxidized lipid compounds and uses thereof | VASCULAR BIOGENICS LTD | 2015-07-22 | — | — | CN | claimed |
| EP-2094737-A1 | CATALYST COMPONENT FOR THE POLYMERIZATION OF OLEFINS | Basell Poliolefine Italia S.r.l. (IT) | 2009-09-02 | — | — | EP | claimed |
| WO-2008061662-A1 | CATALYST COMPONENT FOR THE POLYMERIZATION OF OLEFINS | BASELL POLIOLEFINE ITALIA S.R.L. (IT) | 2008-05-29 | — | — | WO | claimed |
| US-5354911-A | From diacetals; catalyst composed of acid and amine | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-10-11 | — | — | US | claimed |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-12275679-B2 | Transition metal-catalyzed production of alcohol and carbonyl compounds from hydrocarbons | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-04-15 | — | — | US | disclosed |
| US-20240286973-A1 | Transition Metal-Catalyzed Production of Alcohol and Carbonyl Compounds From Hydrocarbons | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2024-08-29 | — | — | US | disclosed |
| US-12017970-B2 | Transition metal-catalyzed production of alcohol and carbonyl compounds from hydrocarbons | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2024-06-25 | — | — | US | disclosed |
| CN-117229132-B | Synthesis method of trans-2, 4-nonadienal | 济南悟通生物科技有限公司 | 2024-02-20 | — | — | CN | disclosed |
| US-20230416169-A1 | Transition Metal-Catalyzed Production of Alcohol and Carbonyl Compounds From Hydrocarbons | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2023-12-28 | — | — | US | disclosed |
| EP-0703211-A1 | Process for the preparation of unsaturated ethers | HÜLS AKTIENGESELLSCHAFT (DE) | 1996-03-27 | — | — | EP | disclosed |
| CN-1031133-C | Pyrazolotriazole derivatives | YAMANOUCHI PHARMA CO LTD (JP) | 1996-02-28 | — | — | CN | disclosed |
| EP-0490221-B1 | Method for the production of unsaturated ethers | HOECHST AG (DE) | 1995-08-09 | — | — | EP | disclosed |
| US-5354911-A | From diacetals; catalyst composed of acid and amine | HOECHST AKTIENGESELLSCHAFT (DE) | 1994-10-11 | — | — | US | disclosed |
| CN-1069978-A | Pyrazolotriazole derivatives | YAMANOUCHI PHARMA CO LTD (JP) | 1993-03-17 | — | — | CN | disclosed |
| EP-0490221-A2 | Method for the production of unsaturated ethers | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-06-17 | — | — | EP | disclosed |
| EP-0060734-B1 | PROCESS FOR THE PREPARATION OF ESTERS OF BETA-GAMMA-UNSATURATED CARBOXYLIC ACIDS | RHONE-POULENC CHIMIE DE BASE (FR) | 1985-03-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | THRB 396/4885DNM1 3850/4885LMNA 4529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.